January 23th, 2024

Earlier this week our research team #AppliedNanotechnology at #Saxion has been awarded a #PioneerInHealthcare voucher (#PIHC). entitled “Continuous glucose monitoring (#CGM) in the intensive care unit”.  This project will be coordinated by Kim Kamphorst from the Deventer Ziekenhuis, and other involved partners are Ziekenhuisgroep Twente (ZGT) and Medisch Spectrum Twente (MST).

Both hyperglycemia (high blood sugar) and hypoglycemia (low blood sugar) in intensive care (ICU) patients are strongly associated with increased morbidity and mortality. Accurate and timely measurement of glucose levels in this population is therefore crucial. Continuous glucose monitoring (CGM) appears promising for this purpose, but it is not yet used in the ICU due to insufficient knowledge about its reliability in the ICU population. The aim of this pilot study is to investigate (1) the discrepancy between CGM and point-of-care measurements in ICU patients, and (2) whether this discrepancy is consistent across all ICU patient groups/characteristics.

Researchers involved are Arriette Kruisdijk-Gerritsen (DZ), Huub van den Oever (DZ), Martin Bennink (Saxion), Aurel Ymeti (Saxion), Bart Grady (ZGT), Hans Krabbe (ZGT, MST), Mattijs Out (MST), en Bert Beishuizen (MST)

View all honored PIHC projects: here
Link to Saxion newsitem: here